VCAM1 and cancer: The remainder of this review goes on to summarise the existing evidence and current developments supporting the anti-colitic and anti-cancer potential of several approved and novel therapeutics that target VCAM-1 in colorectal pathologies (listed in Tables 1, 2, and 3).